Recently, an international commission proposed a revised definition of obesity that focuses on how excess body fat affects the body, and factors in waist circumference, rather than simply ...

The proposed recommendations, endorsed by more than 75 medical organisations around the world, are designed to address limitations in the traditional definition and diagnosis of obesity that ...

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics revealing plans to go public while Hong Kong-listed Ascentage Pharma joins ...

“As a physician of internal medicine, specialising in endocrinology, I treat patients with obesity, Type 2 diabetes, sleep apnoea, high cholesterol and so on. So many open their consultations by ...

Dr. Rajan explained, "If you think obesity is just about willpower, you don't fully understand this complex metabolic condition." He went on to clarify, "What Oprah is referring to here is called ...

This result, if confirmed in larger trials, could give the medicine an edge over available obesity treatments.

The phase 1b/2a study compared the GLP-1 and amylin receptor agonist to placebo in 125 people who are overweight or with obesity. Patients achieved an estimated weight loss of 9.7% on 1.25 mg ...

Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. In a few short years, excitement about groundbreaking anti-obesity drugs made Novo Nordisk Europe’s ...